Contributors
James L. Abbruzzese(Duke University), Jörge E. Cortes(Augusta University Health), Géza Ács(AdventHealth Tampa), Sachin M. Apte, Carolyn C. Compton(University of Arizona), Julie R. Brahmer(Johns Hopkins University), Steven R. Alberts(North Central Cancer Treatment Group), William J. Blot(Shanghai Cancer Institute), Martin D. Abeloff(Johns Hopkins University), Robert E. Coleman, Claudia Beghé, Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center), Charles L. Bennett(University of South Carolina), Leslie A. Andritsos(University of New Mexico), Mamad M. Bagheri, Charles M. Balch(The University of Texas MD Anderson Cancer Center), Anthony J. Cmelak(Breast Cancer Research Foundation), Robert S. Benjamin(The University of Texas MD Anderson Cancer Center), Donna Bernstein, Joseph Aisner(Rutgers, The State University of New Jersey), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David P. Carbone(Vanderbilt University), Jamés O. Armitage(University of Nebraska Medical Center), Janet L. Abrahm(Harvard University), Malcom V. Brock(Johns Hopkins University), Dario Campana(National University of Singapore), Richard F. Ambinder(Johns Hopkins University), Lodovico Balducci(Moffitt Cancer Center), Jeffery S. Abrams, Ali Bydon(Johns Hopkins University), Linda D. Cooley, Ghassan K. Abou‐Alfa(Memorial Sloan Kettering Cancer Center), Ross S. Berkowitz(Dana-Farber Brigham Cancer Center), Michael F. Clarke(La Trobe University), Rhoda M. Alani(Boston University), Michael R. Bishop(University of Chicago), Deborah K. Armstrong(Johns Hopkins University), Viven H.C. Bramwell, Alfred E. Chang(University of Michigan), Daniel W. Chan(Johns Hopkins University), Peter F. Coccia(North Central Cancer Treatment Group), Michael J. Borowitz(Johns Hopkins University), Manpreet Chadha, Leslie H. Blumgart(Memorial Sloan Kettering Cancer Center), Alfred M. Cohen(American Society of Clinical Oncology), Michaele C. Christian(Walter Reed Army Institute of Research), H. Ballentine Carter, Mitchell S. Cairo(New York Medical College), Seena C. Aisner, Guido T. Bommer(de Duve Institute)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k